about
Hypertension due to blockade of adenosine receptors.Activation of adenosine receptors improves renal antioxidant status in diabetic Wistar but not SHR ratsResolving Inflammation in Heart Failure: Novel Protective Lipid Mediators.Aspirin and blood pressure: Effects when used alone or in combination with antihypertensive drugs.Statins and oxidative stress in chronic heart failure.Longer duration of obesity is associated with a reduction in urinary angiotensinogen in prepubertal children.Association of myeloperoxidase levels with cardiometabolic factors and renal function in prepubertal children.Urinary fibrogenic cytokines ET-1 and TGF-β1 are associated with urinary angiotensinogen levels in obese children.Gender and obesity modify the impact of salt intake on blood pressure in children.Xanthine oxidase inhibition by 1,3-dipropyl-8-sulfophenylxanthine (DPSPX), an antagonist of adenosine receptors.Scavenging of nitric oxide by an antagonist of adenosine receptors.Oxidative stress and nitric oxide are increased in obese children and correlate with cardiometabolic risk and renal function.Role of superoxide and hydrogen peroxide in hypertension induced by an antagonist of adenosine receptors.Diabetes-induced increase of renal medullary hydrogen peroxide and urinary angiotensinogen is similar in normotensive and hypertensive rats.Pre- and postjunctional effects of angiotensin II in hypertension due to adenosine receptor blockade.Inhibition of nociceptive responses of spinal cord neurones during hypertension involves the spinal GABAergic system and a pain modulatory center located at the caudal ventrolateral medulla.Lesion of the caudal ventrolateral medulla prevents the induction of hypertension by adenosine receptor blockade in rats.Research update for articles published in EJCI in 2014l-proline supplementation improves nitric oxide bioavailability and counteracts the blood pressure rise induced by angiotensin II in ratsResearch update for articles published in EJCI in 2016Impaired resolution of inflammation in human chronic heart failure
P50
Q35129956-68679088-5AEE-489A-BED5-B68335891293Q37564150-D47E4A14-A3E7-46ED-A56F-C061F6BEDA4EQ38684375-A211BC2B-4F43-43DD-B1B7-304EC3583B07Q38690530-D06CD817-D6E4-4D45-8896-6877ACCCECAEQ38695806-C1AA89CF-4F78-4DFA-8259-8A81644A9BB1Q38740569-6EF2B421-5A07-4CE6-9548-D73DFBC3D332Q41146478-FD4A6506-E70C-468A-8924-F9D71174A620Q41202467-78093D8F-D075-4F34-B7B5-F5AEFD357C1FQ41288115-B99EB2FF-BBE9-470E-B318-4B5AFDB533CBQ44940405-20636445-2465-48EF-B3C0-2F4D18F7484EQ46419822-22287090-889C-4BF4-88DB-332877968465Q46507693-FABC9215-2650-455F-AC98-5993223D9C27Q46562981-42C00FBF-1F84-4E61-9E4D-818149DA4DF2Q46889855-C2F37DAA-5646-4888-A851-496CD75BA1B4Q46913143-879D7A37-2E18-40B2-8A87-14AAC91568AFQ46924055-B9A15C61-E99C-4E3B-AFF3-8E813AA865C9Q46927088-A7767D58-3F05-44B6-97BD-44BCB41F4A46Q58197547-2293C302-455F-4B44-8805-EDBFA0725A28Q63434116-D45E18FB-C3A0-4C75-97C4-CFA2C2B90915Q63434118-86023A45-4622-4244-B10F-2A13A15947EEQ63434120-960722F6-8073-433C-9A86-843CF9143BCB
P50
description
hulumtuese
@sq
researcher
@en
հետազոտող
@hy
name
Teresa Sousa
@ast
Teresa Sousa
@en
Teresa Sousa
@es
Teresa Sousa
@nl
Teresa Sousa
@sl
type
label
Teresa Sousa
@ast
Teresa Sousa
@en
Teresa Sousa
@es
Teresa Sousa
@nl
Teresa Sousa
@sl
prefLabel
Teresa Sousa
@ast
Teresa Sousa
@en
Teresa Sousa
@es
Teresa Sousa
@nl
Teresa Sousa
@sl
P108
P106
P108
P1153
6603380101
P21
P31
P496
0000-0001-7230-5020